Terbinafine Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition
Terbinafine Hydrochloride Price Trend, Index and Forecast
Track the latest insights on terbinafine hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Terbinafine Hydrochloride Prices Outlook Q1 2026
- USA: USD 211/KG
- India: USD 97/KG
- Germany: USD 128/KG
- Brazil: USD 161/KG
- Spain: USD 142/KG
Terbinafine Hydrochloride Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the first quarter of 2026, the terbinafine hydrochloride prices in the USA reached 211 USD/KG in March. Prices moved upward as pharmaceutical buyers increased restocking after cautious procurement in the previous quarter. Demand from antifungal formulations remained firm, supported by steady consumption in dermatology and prescription based treatment channels.
During the first quarter of 2026, the terbinafine hydrochloride prices in India reached 97 USD/KG in March. Prices increased as domestic formulation demand improved and active pharmaceutical ingredient producers faced firmer input costs. Procurement from tablet and topical medicine manufacturers remained steady, with buyers securing material ahead of scheduled production cycles. Export interest also supported market sentiment, especially from buyers seeking competitively priced Indian supply.
During the first quarter of 2026, the terbinafine hydrochloride prices in Germany reached 128 USD/KG in March. Prices rose as pharmaceutical procurement remained firm across antifungal formulation channels. Buyers maintained regular purchasing due to stable prescription demand and the need to secure compliant material from qualified suppliers. Import costs were elevated, supported by stronger freight, documentation, and quality assurance expenses.
During the first quarter of 2026, the terbinafine hydrochloride prices in Brazil reached 161 USD/KG in March. Prices increased as import dependent supply chains faced firmer overseas offers and higher landed cost pressure. Domestic demand from pharmaceutical formulators remained stable, supported by continued consumption of antifungal medicines. Buyers replenished inventories after limited purchasing in the previous quarter, which strengthened spot activity.
During the first quarter of 2026, the terbinafine hydrochloride prices in Spain reached 142 USD/KG in March. Prices moved upward due to consistent demand from pharmaceutical formulation units and firm import offers from key supplying regions. Buyers focused on maintaining adequate inventories for antifungal dosage production, while suppliers kept quotations strong amid rising production and logistics costs. European regulatory and quality documentation requirements added to procurement expenses, supporting higher landed prices.
Terbinafine Hydrochloride Prices Outlook Q1 2025
- USA: USD 196/KG
- India: USD 90/KG
- Germany: USD 116/KG
- Brazil: USD 150/KG
- Spain: USD 132/KG
During the first quarter of 2025, the terbinafine hydrochloride prices in the USA reached 196 USD/KG in March. As per the terbinafine hydrochloride price chart, prices varied due to worries about trade and uncertainty regarding supply. January experienced a surge due to the acceleration of pre-tariff imports and increasing logistical expenses. Prices fell in February as China restarted production and shipping became easier. By March, prices were revived by renewed purchasing and concerns related to tariffs.
During the first quarter of 2025, the terbinafine hydrochloride prices in India reached 90 USD/KG in March. The market experienced significant fluctuations. Driven by increasing pharmaceutical exports and domestic demand, bolstered by global restocking, prices surged in January. In February, a downturn occurred due to supply exceeding demand, leading buyers to steer clear of new purchases. March experienced a rebound as exporters hurried shipments to the U.S. before looming tariffs, which tightened local availability.
During the first quarter of 2025, the terbinafine hydrochloride prices in Germany reached 116 USD/KG in March. Prices were subject to fluctuations. The moderate gains in January were driven by strong demand in the healthcare sector and strategic stockpiling. February experienced a price decline owing to adequate supply, robust Euro performance, and reduced shipping expenses. The mild recovery observed in March was ascribed to supply delays caused by labor unrest and port congestion.
During the first quarter of 2025, the terbinafine hydrochloride prices in Brazil reached 150 USD/KG in March. Prices fluctuated as a result of varying demand and external factors such as enhanced logistics and accumulated inventories. In March, a resurgence in demand for pharmaceuticals and supply chain issues led to a slight recovery in prices. The quarter concluded with slight gains, indicative of a market adjusting to changes in global trade and localized supply constraints.
During the first quarter of 2025, the terbinafine hydrochloride prices in Spain reached 132 USD/KG in March. The market experienced fluctuations. Prices rose in January because of proactive buying ahead of the Chinese New Year and robust demand from the pharmaceutical sector. February experienced a decline due to steady imports, reduced transport rates, and inventory accumulation, which diminished buying momentum.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing terbinafine hydrochloride prices.
Europe Terbinafine Hydrochloride Price Trend
Q1 2026:
In Europe, the terbinafine hydrochloride price index moved upward, supported by firm pharmaceutical demand and higher import replacement costs. Germany and Spain reflected stronger buying interest as formulation manufacturers secured material for regular production schedules. Suppliers maintained firm offers due to higher input, quality compliance, and logistics expenses. Buyers focused on reliable sourcing, especially for material meeting pharmaceutical grade documentation standards. Demand from antifungal medicine channels remained steady, helping sellers defend higher quotations.
Q1 2025:
As per the terbinafine hydrochloride price index, there were significant fluctuations driven by alterations in demand and supply dynamics. January saw a moderate rise, fueled by robust demand from major European markets and stockpiling efforts in anticipation of the Chinese Lunar New Year. In February, prices softened due to stable supply and weakening demand. Moreover, in March, supply disruptions due to port congestion and labor strikes contributed to a minor price hike. As the pharmaceutical sector began to recover and restocking activities intensified, demand increased, resulting in a slight price rebound.
This analysis can be extended to include detailed terbinafine hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Terbinafine Hydrochloride Price Trend
Q1 2026:
In North America, the terbinafine hydrochloride price index increased as buyers resumed replenishment after earlier caution. The United States market was supported by stable demand from oral and topical antifungal formulation channels. Importers faced firmer supplier offers from overseas producers, which lifted landed costs. Distributors increased purchasing to maintain stock continuity and reduce shipment risk. Price support also came from higher compliance, freight, and handling expenses. Buyers continued to prioritize qualified sources, allowing sellers to maintain stronger quotations.
Q1 2025:
The market varied as a result of unpredictable supply chain issues and changing trade policies. This, combined with escalating energy expenses and the imminent arrival of the Chinese Lunar New Year, resulted in a temporary price surge. In February, however, costs declined as production in China recovered after the holiday and freight rates fell, leading to improved import flows. Market conditions were weakened by economic uncertainty and decreased demand from prior stockpiling. Prices saw a slight increase by March due to concerns about the continuity of pharmaceutical supply following tariff announcements from the U.S. government. The quarter ended with a slight price recovery, fueled by renewed buying interest and ongoing concerns about the supply chain.
Specific terbinafine hydrochloride historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Terbinafine Hydrochloride Price Trend
Q1 2026:
The study examines the price patterns of terbinafine hydrochloride throughout the Middle East and Africa, taking into account variables that specifically affect market prices, such as regional industrial expansion, the availability of natural resources, and geopolitical conflicts.
Q1 2025:
The report explores the terbinafine hydrochloride trends and terbinafine hydrochloride price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on terbinafine hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Terbinafine Hydrochloride Price Trend
Q1 2026:
In the Asia Pacific, terbinafine hydrochloride prices increased as demand improved across key pharmaceutical manufacturing hubs. India saw stronger procurement from formulation producers, while regional buyers showed better interest in active pharmaceutical ingredient availability. Producers lifted offers due to higher production costs, stronger intermediate values, and better export inquiries. Distributor restocking supported market activity after cautious purchases in the previous quarter. Supply was available, but sellers resisted lower bids due to improved demand visibility.
Q1 2025:
Prices in India showed a volatile pattern due to changes in demand and supply factors. In January, prices improved due to the growth of domestic pharmaceutical sales and rising exports in expectation of higher tariffs. The growth of the Indian Pharma Market, coupled with robust international demand, enabled suppliers to increase prices. February saw a decline, as consistent domestic production fulfilled supply needs and global demand weakened amid uncertainties in the U.S. and Europe. Prices bounced back in March due to the tightening of domestic supplies and Indian exporters accelerating their shipments to the U.S. in anticipation of the April tariff deadline.
This terbinafine hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Terbinafine Hydrochloride Price Trend
Q1 2026:
In Latin America, terbinafine hydrochloride prices moved upward, led by stronger import costs and steady pharmaceutical demand. Brazil reflected firmer pricing as distributors and formulation buyers replenished inventories. Regional markets remained exposed to overseas supplier quotations, freight charges, and currency related procurement risks. Buyers showed greater interest in securing supply from qualified vendors, especially for antifungal formulation production.
Q1 2025:
Prices in India showed a volatile pattern due to changes in demand and supply factors. In January, prices improved due to the growth of domestic pharmaceutical sales and rising exports in expectation of higher tariffs. The growth of the Indian Pharma Market, coupled with robust international demand, enabled suppliers to increase prices. February saw a decline, as consistent domestic production fulfilled supply needs and global demand weakened amid uncertainties in the U.S. and Europe. Prices bounced back in March due to the tightening of domestic supplies and Indian exporters accelerating their shipments to the U.S. in anticipation of the April tariff deadline.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Terbinafine Hydrochloride Pricing Report, Market Analysis, and News
IMARC's latest publication, “Terbinafine Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the terbinafine hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of terbinafine hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed terbinafine hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting terbinafine hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Terbinafine Hydrochloride Industry Analysis
The global terbinafine hydrochloride industry size reached USD 1.5 Billion in 2025. By 2034, IMARC Group expects the market to reach USD 3.5 Billion, at a projected CAGR of 9.87% during 2026-2034. Growth is supported by sustained demand for antifungal treatments, rising use of topical and oral dermatology formulations, and growing pharmaceutical production in cost efficient manufacturing regions.
Latest News and Developments:
- In 2024, Novartis revealed ALITHIOS study data demonstrating Kesimpta's sustained efficacy over six years for treatment-naïve individuals with relapsing multiple sclerosis: 44% fewer relapses, 96.4% and 82.7% MRI lesion reductions, and 24.5% and 21.6% fewer 3- and 6-month disability worsening events compared to teriflunomide switchers. Similar efficacy and safety were observed across the ALITHIOS population.
- In 2023, Taro Pharmaceutical Industries Ltd. (PINK SHEETS: (TAROF) Celebrates FDA's Final Approval of Its Abbreviated New Drug Application (ANDA) Submission for Terbinafine Hydrochloride Cream, 1%. This implies conditional approval, which is a step towards the drug pipeline expansion of Taro Biopharm.
- In 2021, Breckenridge Pharmaceutical, Inc. announced a multi-product agreement with Aggrega Pharma, LLC., covering eight products in various dosage forms. The agreement includes one approved ANDA, four submitted to the FDA, and three in advanced development stages.
Product Description
Terbinafine hydrochloride is a synthetic allylamine antifungal active pharmaceutical ingredient used in oral and topical medicines for fungal infections of the skin and nails. It is the hydrochloride salt of terbinafine and has the molecular formula C21H26ClN, with a molecular weight of 327.90. The product is generally described as a white to off white crystalline powder. It is freely soluble in methanol and methylene chloride, soluble in ethanol, and slightly soluble in water. Terbinafine hydrochloride acts by inhibiting fungal squalene epoxidase, which disrupts ergosterol synthesis and weakens fungal cell membrane function. It is widely used in tablets, creams, gels, sprays, and other antifungal dosage forms for dermatology applications. Its industrial demand is mainly linked to pharmaceutical manufacturing, contract formulation, and antifungal product distribution. Product characteristics and antifungal classification are supported by PubChem, DrugBank, and FDA labeling information.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Terbinafine Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Terbinafine Hydrochloride Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of terbinafine hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of FOB and CIF prices.
- The study examines factors affecting terbinafine hydrochloride price trend, including input costs, supply-demand shifts, and geopolitical impacts, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The terbinafine hydrochloride price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: [email protected]
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.